|
Balaxi Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
288.57 Cr.
|
P/BV
|
1.34
|
Book Value (Rs.)
|
39.10
|
|
52 Week High/Low (Rs.)
|
151/50
|
FV/ML
|
2/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/05/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 241.29 | 336.43 | 279.39 | 231.33 | 45.63 |
| Total Operating Revenues | 241.29 | 336.43 | 279.39 | 231.33 | 45.63 |
| | | | | | |
| Other Income | -2.65 | 2.64 | 4.97 | 2.23 | 2.81 |
| Total Revenue | 238.65 | 339.07 | 284.36 | 233.56 | 48.44 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 128.68 | 202.42 | 195.60 | 172.15 | 33.58 |
| Employee Benefit Expenses | 28.04 | 28.95 | 12.47 | 8.47 | 2.10 |
| Finance Costs | 1.68 | 0.50 | 0.14 | 0.01 | 0.00 |
| Depreciation And Amortisation Expenses | 2.10 | 1.75 | 0.51 | 0.30 | 0.01 |
| Other Expenses | 37.85 | 48.53 | 21.12 | 8.30 | 3.89 |
| Total Expenses | 198.34 | 282.15 | 229.84 | 189.23 | 39.57 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 40.31 | 56.92 | 54.52 | 44.33 | 8.87 |
| | | | | | |
| Exceptional Items | -38.29 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 2.02 | 56.92 | 54.52 | 44.33 | 8.87 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 4.51 | 9.90 | 6.83 | 6.19 | 2.77 |
| Deferred Tax | -0.11 | 1.06 | 0.03 | 0.00 | 0.00 |
| Total Tax Expenses | 4.40 | 10.96 | 6.86 | 6.19 | 2.77 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -2.39 | 45.96 | 47.66 | 38.14 | 6.10 |
| | | | | | |
| Profit/Loss From Continuing Operations | -2.39 | 45.96 | 47.66 | 38.14 | 6.10 |
| | | | | | |
| Profit/Loss For The Period | -2.39 | 45.96 | 47.66 | 38.14 | 6.10 |
| Consolidated Profit/Loss After MI And Associates | -2.39 | 45.96 | 47.66 | 38.14 | 6.10 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -2.32 | 45.81 | 47.66 | 38.14 | 8.12 |
| Diluted EPS (Rs.) | -2.31 | 45.40 | 47.66 | 38.14 | 8.12 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 0.50 | 0.00 | 0.00 | 0.00 |
